Equity Analyst Upgrades and Downgrades of These Stocks Dec 14th

Wall St. Watchdog reveals information about companies for which stock analysts either upgraded or downgraded the shares on December 14th.

Upgrades

  • Avon Products (NYSE:AVP): Caris & Company upgraded its rating on this company from Average to Above Average and changed its price target from $21 to $19. About the company: Avon Products, Inc. manufactures and direct sells beauty and related products. The Company markets its products to consumers worldwide through independent sales representatives. Avon’s product line includes beauty, fashion and home. Get the most recent company news and stock data here >>
  • American Wdmrk (NASDAQ:AMWD): Robert W. Baird upgraded its rating on this company from Neutral to Outperform and changed its price target from $14 to $16. About the company: American Woodmark Corporation manufactures kitchen cabinets and vanities for the remodeling and new home construction markets. The Company offers a wide variety of cabinet lines differing by design, material, and finishes. American Woodmark’s products are sold throughout the United States through independent distributors and directly to home centers, builders, and home manufacturers. Get the most recent company news and stock data here >>
  • Acme Packet (NASDAQ:APKT): Morgan Keegan upgraded its rating on this company from Mkt Perform to Outperform and changed its price target to $45. About the company: Acme Packet, Inc. provides session border controllers for Internet service providers. The Company’s products consist of hardware and proprietary software that allow service providers to deliver interactive communications services such as voice over Internet protocol. Get the most recent company news and stock data here >>

Downgrades

  • Toll Brothers (NYSE:TOL): Stifel Nicolaus downgraded its rating on this company from Hold to Sell. About the company: Toll Brothers, Inc. builds luxury homes, serving both move-up and empty nester buyers in several regions of the United States. The Company builds customized single and attached homes, primarily on land that it develops and improves. Toll Brothers also operates its own architectural, engineering, mortgage, title, security, landscape, insurance brokerage, and manufacturing operations. Get the most recent company news and stock data here >>
  • DR Horton (NYSE:DHI): Stifel Nicolaus downgraded its rating on this company from Hold to Sell. About the company: D.R. Horton, Inc. constructs and sells single-family homes designed primarily for the entry-level and move-up markets. The Company operates in the Midwest, Mid-Atlantic, Southeast, Southwest, and Western regions of the United States. D.R. Horton also, through its financial services operations, provide mortgage financing and title agency services to homebuyers. Get the most recent company news and stock data here >>
  • Altria (NYSE:MO): Stifel Nicolaus downgraded its rating on this company from Buy to Hold. About the company: Altria Group, Inc. is a holding company. The Company, through subsidiaries, manufactures and sells cigarettes and other tobacco products, including cigars and pipe tobacco. Altria holds an interest in a brewery company. Get the most recent company news and stock data here >>
  • Volterra Semi (NASDAQ:VLTR): Needham downgraded its rating on this company from Strong Buy to Buy and changed its price target from $29 to $28. About the company: Volterra Semiconductor Corp. designs, develops, and markets proprietary, high performance analog and mixed-signal power management semiconductors for the computing, storage, networking and consumer markets. The Company’s core products are integrated-voltage regulator semiconductors and scalable voltage semiconductor chipsets. Get the most recent company news and stock data here >>

(Note: Selected financial data are sourced from Briefing.com via the Wall St. Journal. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>